These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22115125)
1. Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII. Swiech K; Kamen A; Ansorge S; Durocher Y; Picanço-Castro V; Russo-Carbolante EM; Neto MS; Covas DT BMC Biotechnol; 2011 Nov; 11():114. PubMed ID: 22115125 [TBL] [Abstract][Full Text] [Related]
2. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction. Kolind MP; Nørby PL; Berchtold MW; Johnsen LB J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947 [TBL] [Abstract][Full Text] [Related]
3. The B-domain of Factor VIII reduces cell membrane attachment to host cells under serum free conditions. Kolind MP; Nørby PL; Flintegaard TV; Berchtold MW; Johnsen LB J Biotechnol; 2010 Jun; 147(3-4):198-204. PubMed ID: 20438774 [TBL] [Abstract][Full Text] [Related]
4. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII. Mannully ST; L N R; Pulicherla KK Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930 [TBL] [Abstract][Full Text] [Related]
5. Expression of factor VIII in recombinant and transgenic systems. Soukharev S; Hammond D; Ananyeva NM; Anderson JA; Hauser CA; Pipe S; Saenko EL Blood Cells Mol Dis; 2002; 28(2):234-48. PubMed ID: 12064919 [TBL] [Abstract][Full Text] [Related]
6. Transgenic pigs produce functional human factor VIII in milk. Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047 [TBL] [Abstract][Full Text] [Related]
7. Production of recombinant human factor VIII in different cell lines and the effect of human XBP1 co-expression. Campos-da-Paz M; Costa CS; Quilici LS; de Carmo Simões I; Kyaw CM; Maranhão AQ; Brigido MM Mol Biotechnol; 2008 Jun; 39(2):155-8. PubMed ID: 18327549 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of Hsp70 in BHK-21 cells engineered to produce recombinant factor VIII promotes resistance to apoptosis and enhances secretion. Ishaque A; Thrift J; Murphy JE; Konstantinov K Biotechnol Bioeng; 2007 May; 97(1):144-55. PubMed ID: 17054114 [TBL] [Abstract][Full Text] [Related]
9. First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely? Suiter TM Semin Thromb Hemost; 2002 Jun; 28(3):277-84. PubMed ID: 12098089 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of marketed factor VIII products: recombinant products are not alike vis-a-vis soluble protein aggregates and subvisible particles. Anzengruber J; Lubich C; Prenninger T; Gringeri A; Scheiflinger F; Reipert BM; Malisauskas M J Thromb Haemost; 2018 Jun; 16(6):1176-1181. PubMed ID: 29665242 [TBL] [Abstract][Full Text] [Related]
11. Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium. Cervera L; Gutiérrez-Granados S; Martínez M; Blanco J; Gòdia F; Segura MM J Biotechnol; 2013 Jul; 166(4):152-65. PubMed ID: 23688724 [TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of a mutant recombinant blood coagulation factor VIII (rFVIII (m)). Oh SH; Cho SY; Jin HS; Jeong DL; Jung SG; Oh KH Exp Mol Med; 2002 Jul; 34(3):233-8. PubMed ID: 12216115 [TBL] [Abstract][Full Text] [Related]
13. Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors. Haldankar R; Li D; Saremi Z; Baikalov C; Deshpande R Mol Biotechnol; 2006 Oct; 34(2):191-9. PubMed ID: 17172664 [TBL] [Abstract][Full Text] [Related]
14. Expression of human coagulation factor VIII in a human hybrid cell line, HKB11. Mei B; Chen Y; Chen J; Pan CQ; Murphy JE Mol Biotechnol; 2006 Oct; 34(2):165-78. PubMed ID: 17172662 [TBL] [Abstract][Full Text] [Related]
15. Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Pham PL; Perret S; Doan HC; Cass B; St-Laurent G; Kamen A; Durocher Y Biotechnol Bioeng; 2003 Nov; 84(3):332-42. PubMed ID: 12968287 [TBL] [Abstract][Full Text] [Related]
16. Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience. Afonja O; Kozak R; Petraro P; Michaels LA; Mathew P; Lemm G; Kessler C Expert Rev Hematol; 2016 Dec; 9(12):1151-1164. PubMed ID: 27841041 [TBL] [Abstract][Full Text] [Related]
17. The relevance of factor VIII (FVIII) pharmacokinetics to TDM and hemophilia a treatment: is B domain-deleted FVIII equivalent to full-length FVIII? Johnston A Ther Drug Monit; 2012 Feb; 34(1):110-7. PubMed ID: 22249347 [TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant factor VIII and a recombinant factor VIII deletion mutant using a rabbit immunogenicity model system. Esmon PC; Kuo HS; Fournel MA Blood; 1990 Oct; 76(8):1593-600. PubMed ID: 1698481 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII. Hermans C; Mahlangu J; Booth J; Schütz H; Santagostino E; Young G; Lee HY; Steinitz-Trost KN; Blanchette V; Berntorp E Haemophilia; 2018 May; 24(3):376-384. PubMed ID: 29732708 [TBL] [Abstract][Full Text] [Related]